Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Acta Haematologica|November 5, 2005
Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cellsNeal Flomenberg, John DiPersio, Gary Calandra
Experimental Hematology|July 26, 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristicsStefan Fruehauf, Timon Seeger, Patrick Maier, et al.
Blood|April 14, 2009
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaJohn F DiPersio, Edward A Stadtmauer, Auayporn Nademanee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myelomaDouglas A Stewart, Clayton Smith, Ron MacFarland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2010
Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantationNeal Flomenberg, Raymond L Comenzo, Karin Badel, et al.
The Journal of Experimental Medicine|April 20, 2005
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonistHal E Broxmeyer, Christie M Orschell, D Wade Clapp, et al.
FEBS Letters|September 11, 2002
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4Sigrid Hatse, Katrien Princen, Gary Bridger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairmentRonald MacFarland, Marjie L Hard, Robert Scarborough, et al.
Stem Cells and Development|September 6, 2007
Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patientsYair Gazitt, Cesar O Freytes, Cagla Akay, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
Pageof 6